Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yuko Takemoto is active.

Publication


Featured researches published by Yuko Takemoto.


Rheumatology | 2009

Association of TLR4 polymorphisms with Behçet's disease in a Korean population

Yukihiro Horie; Akira Meguro; Masao Ota; Nobuyoshi Kitaichi; Yoshihiko Katsuyama; Yuko Takemoto; Kenichi Namba; Kazuhiko Yoshida; Yeong Wook Song; Kyung Sook Park; Eun Bong Lee; Hidetoshi Inoko; Nobuhisa Mizuki; Shigeaki Ohno

OBJECTIVES HLA-B51 is strongly associated with Behçets disease (BD) in any ethnic background. We recently reported that another gene, Toll-like receptor-4 (TLR4) is also implicated in BD in a Japanese population. To confirm these results, we investigated polymorphisms in the TLR4 gene in Korean patients with BD. METHODS In this study, 119 patients with BD and 141 healthy controls were enrolled; every participant was a Korean. Nine single nucleotide polymorphisms previously detected in TLR4 by direct sequencing were analysed for an association with BD. RESULTS The most frequent haplotype, TAGCGGTAA, was significantly increased in HLA-B*51-positive BD patients (49.5%), compared with healthy control participants [32.3%; P = 0.029; odds ratio (OR) = 2.01; 95% CI 1.25-3.23]. This haplotype was also significantly increased in BD patients with arthritis (48.2%; P = 0.003; OR = 1.96; 95% CI 1.26-3.26). There were no significant differences in the allele and genotype frequencies of patients and controls for each single nucleotide polymorphism. CONCLUSIONS The haplotype of TLR4 may increase the risk for developing BD and the complication of arthritis in the Korean population.


British Journal of Ophthalmology | 2016

Choroidal thickening prior to anterior recurrence in patients with Vogt–Koyanagi–Harada disease

Yoshiaki Tagawa; Kenichi Namba; Kazuomi Mizuuchi; Yuko Takemoto; Daiju Iwata; Tomoe Uno; Takako Fukuhara; Kiriko Hirooka; Nobuyoshi Kitaichi; Shigeaki Ohno; Susumu Ishida

Aim To assess choroidal thickness changes associated with anterior segment recurrences in patients with Vogt–Koyanagi–Harada (VKH) disease using enhanced depth imaging optical coherence tomography (EDI-OCT). Methods EDI-OCT images were obtained periodically from 11 patients with VKH disease (22 eyes) who were followed-up due to anterior segment recurrences. Subfoveal choroidal thickness (SCT) values at the following stages were evaluated: (1) during the remission phase, (2) 1 month before detecting the anterior recurrence, (3) during the anterior recurrence and (4) after systemic prednisolone (PSL) treatment leading to remission. In comparison with SCT values in remission as baseline, the changing ratios of SCT were statistically analysed at subsequent three stages. Results The average of the SCT changing ratios compared with the remission phase significantly increased to 1.45±0.11 during anterior segment recurrences (p=0.00044) lacking any funduscopic signs of posterior involvement. Interestingly, the average SCT ratio 1 month before detecting the recurrence had already increased to 1.30±0.08 (p=0.002). After the PSL treatment, the ratio of SCT recovered to 0.95±0.03, which was equivalent to the remission level. However, in patients with their remission SCT values less than 240 µm, the SCT ratio did not increase significantly at any time points evaluated. Conclusions The choroid in eyes with VKH disease thickened in association with the anterior segment recurrence, and this thickening was observed prior to the recurrence. EDI-OCT may be useful for detecting latent choroidal inflammation in VKH disease, whereas it may not for patients with the relatively thin choroid. Trial registration number The trial registration number of the internal review board of Hokkaido University Hospital is 014-0384.


European Journal of Ophthalmology | 2013

Two Cases of Subfoveal Choroidal Neovascularization with Tubulointerstitial Nephritis and Uveitis Syndrome

Yuko Takemoto; Kenichi Namba; Kazuomi Mizuuchi; Shigeaki Ohno; Susumu Ishida

Purpose. Tubulointerstitial nephritis and uveitis (TINU) syndrome usually shows anterior segment intraocular inflammation, but severe posterior segment intraocular inflammation is rarely observed. We report 2 children with TINU syndrome complicated by subfoveal choroidal neovascularization (CNV). Methods. Case reports. Results. Patients were a 12-year-old girl and a 12-year-old boy diagnosed with probable TINU syndrome on the basis of typical ocular findings and high value of urinary β2 microglobulin even though renal biopsy was not performed. The girl showed development of CNV with subretinal macular hemorrhage along with the exacerbation of anterior chamber inflammation in her left eye. Subretinal macular hemorrhage recurred frequently even with oral prednisolone; therefore, intravitreal injection of bevacizumab (IVB) was performed. After IVB, the subretinal proliferative tissue shrunk and subretinal hemorrhage has not recurred for 5 years. The boy showed subretinal hemorrhage from CNV with severe anterior chamber inflammation in his left eye. With oral prednisolone, anterior chamber inflammation and subretinal hemorrhage disappeared, but shrunken subretinal fibrosis in the macula remained. Final visual acuity was poor due to residual subretinal fibrosis in both cases. Conclusions. Tubulointerstitial nephritis and uveitis syndrome has a potential to develop CNV that leads to severe visual loss; therefore, prompt anti-inflammatory therapy is required, and IVB should be regarded as a potential choice of treatment.


Acta Ophthalmologica | 2016

Choroidal circulation impairment during the anterior recurrence of Vogt-Koyanagi-Harada disease confirmed with indocyanine green angiography and laser speckle flowgraphy.

Yuko Takemoto; Kenichi Namba; Kazuomi Mizuuchi; Daiju Iwata; Tomoe Uno; Shigeaki Ohno; Kiriko Hirooka; Yuki Hashimoto; Wataru Saito; Kazuhisa Sugiyama; Susumu Ishida

To assess choroidal inflammation‐related circulatory changes associated with the anterior recurrence of Vogt–Koyanagi–Harada (VKH) disease, using indocyanine green angiography (ICGA) and laser speckle flowgraphy (LSFG).


Experimental Eye Research | 2004

The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo

Iliyana Ilieva; Kazuhiro Ohgami; Kenji Shiratori; Yoshikazu Koyama; Kazuhiko Yoshida; Satoru Kase; Hirokuni Kitamei; Yuko Takemoto; Kazunaga Yazawa; Shigeaki Ohno


Graefes Archive for Clinical and Experimental Ophthalmology | 2015

Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt–Koyanagi–Harada disease

Kiriko Hirooka; Wataru Saito; Kenichi Namba; Yuko Takemoto; Kazuomi Mizuuchi; Tomoe Uno; Yoshiaki Tagawa; Yuki Hashimoto; Susumu Ishida


Molecular Vision | 2006

Tyrosinase gene family and Vogt-Koyanagi-Harada disease in Japanese patients.

Yukihiro Horie; Yuko Takemoto; Akiko Miyazaki; Kenichi Namba; Satoru Kase; Kazuhiko Yoshida; Masao Ota; Yukiko Hasumi; Hidetoshi Inoko; Nobuhisa Mizuki; Shigeaki Ohno


Molecular Vision | 2007

Polymorphism of IFN-gamma gene and Vogt-Koyanagi-Harada disease.

Yukihiro Horie; Nobuyoshi Kitaichi; Yuko Takemoto; Kenichi Namba; Kazuhiko Yoshida; Shigeto Hirose; Yukiko Hasumi; Masao Ota; Hidetoshi Inoko; Nobuhisa Mizuki; Shigeaki Ohno


Graefes Archive for Clinical and Experimental Ophthalmology | 2012

Correlation between elevation of serum antinuclear antibody titer and decreased therapeutic efficacy in the treatment of Behçet’s disease with infliximab

Daiju Iwata; Kenichi Namba; Kazuomi Mizuuchi; Nobuyoshi Kitaichi; Satoru Kase; Yuko Takemoto; Shigeaki Ohno; Susumu Ishida


Tissue Antigens | 2008

Re-evaluation of heterogeneity in HLA-B*510101 associated with Behçet’s disease

Yuko Takemoto; Taeko Naruse; Kenichi Namba; Nobuyoshi Kitaichi; Masao Ota; Y. Shindo; Nobuhisa Mizuki; Ahmet Gül; W. Madanat; Hormoz Chams; F. Davatchi; Hidetoshi Inoko; Shigeaki Ohno; Akinori Kimura

Collaboration


Dive into the Yuko Takemoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nobuyoshi Kitaichi

Health Sciences University of Hokkaido

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge